Trial intelligence / Profile preview

Bioequivalence study of Ipren versus Brufen 200 mg ibuprofen tablets in healthy adults

2013-001442-34Phase 4Completed

Sponsor
McNeil Laboratories
Start
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ibuprofen 600 mg ER and ibuprofen in pain (2 arms), sponsored by McNeil Laboratories. Primary endpoints: Cmax of S-(+) ibuprofen and AUCt of S-(+) ibuprofen. Started Jun 2013; status: completed.

02

Drugs

ibuprofen 600 mg ERibuprofen
03

Conditions

pain

Beyond the preview

Go deeper on 2013-001442-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001442-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call